190 related articles for article (PubMed ID: 11746830)
1. Decreased mitogenic response to epidermal growth factor in human squamous cell carcinoma lines overexpressing epidermal growth factor receptor owing to limiting amounts of the adaptor protein Grb2: rescue by retinoic acid treatment.
Crowe DL; Tsang KJ
Mol Carcinog; 2001 Dec; 32(4):187-94. PubMed ID: 11746830
[TBL] [Abstract][Full Text] [Related]
2. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
[TBL] [Abstract][Full Text] [Related]
3. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
5. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
Justman QA; Clinton GM
J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
[TBL] [Abstract][Full Text] [Related]
6. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
7. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor.
Rojas M; Yao S; Lin YZ
J Biol Chem; 1996 Nov; 271(44):27456-61. PubMed ID: 8910327
[TBL] [Abstract][Full Text] [Related]
8. Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody.
Huang ZQ; Buchsbaum DJ; Raisch KP; Bonner JA; Bland KI; Vickers SM
J Surg Res; 2003 May; 111(2):274-83. PubMed ID: 12850474
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects.
Raspaglio G; Ferrandina G; Ferlini C; Scambia G; Ranelletti FO
Oncol Res; 2003; 14(2):83-91. PubMed ID: 14649542
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid affects the EGF-R signaling pathway during differentiation induction of human endometrial adenocarcinoma cells.
Carter CA; Shaw BL
Exp Mol Pathol; 2000 Jun; 68(3):170-86. PubMed ID: 10816385
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway.
Crowe DL; Kim R; Chandraratna RA
Mol Cancer Res; 2003 May; 1(7):532-40. PubMed ID: 12754300
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor stimulates the anchorage-independent growth of human squamous cell carcinomas overexpressing its receptors.
Lee K; Tanaka M; Shigeno C; Yamamoto I; Ohta S; Rikimaru K; Hatanaka M; Konishi J
Biochem Biophys Res Commun; 1990 May; 168(3):905-11. PubMed ID: 2346491
[TBL] [Abstract][Full Text] [Related]
14. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines.
Tsang DK; Crowe DL
Int J Oncol; 1999 Sep; 15(3):519-23. PubMed ID: 10427134
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
16. α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.
Yang L; Wen Y; Lv G; Lin Y; Tang J; Lu J; Zhang M; Liu W; Sun X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):325-331. PubMed ID: 28993193
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
Ansell A; Jedlinski A; Johansson AC; Roberg K
J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
[TBL] [Abstract][Full Text] [Related]
19. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
20. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
